Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort.

Ziade N, Hmamouchi I, Moussallem M, Salameh BL, Yaadav P, Makol A, Milchert M, Velikova T, Parodis I, Nikiphorou E, Agarwal V, Gupta L, COVAD Study Group

Open source

DOI: 10.1007/s00296-026-06119-y
Published: 2026 May 13
Container: Rheumatology international
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00296-026-06119-y,
  title = {Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort.},
  author = {Ziade N and Hmamouchi I and Moussallem M and Salameh BL and Yaadav P and Makol A and Milchert M and Velikova T and Parodis I and Nikiphorou E and Agarwal V and Gupta L and COVAD Study Group},
  year = {2026},
  journal = {Rheumatology international},
  doi = {10.1007/s00296-026-06119-y},
  url = {https://doi.org/10.1007/s00296-026-06119-y}
}

RIS

TY  - JOUR
TI  - Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort.
AU  - Ziade N
AU  - Hmamouchi I
AU  - Moussallem M
AU  - Salameh BL
AU  - Yaadav P
AU  - Makol A
AU  - Milchert M
AU  - Velikova T
AU  - Parodis I
AU  - Nikiphorou E
AU  - Agarwal V
AU  - Gupta L
AU  - COVAD Study Group
PY  - 2026
JO  - Rheumatology international
DO  - 10.1007/s00296-026-06119-y
UR  - https://doi.org/10.1007/s00296-026-06119-y
ER  -

APA

N, Z., I, H., M, M., BL, S., P, Y., A, M., M, M., T, V., I, P., E, N., V, A., L, G., & Group, C. S. (2026). Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort.. Rheumatology international. https://doi.org/10.1007/s00296-026-06119-y

Source records

pubmed · retrieved 2026-09-25T23:58:44.481Z